Le Cesne A - Search Results

1

Fizazi K, Cojean I, Le Cesne A, Kayitalire L, Le Chevalier T, Tursz T, Spielmann M. Fizazi K, et al. Among authors: le chevalier t, le cesne a. Bull Cancer. 1994 Oct;81(10):835-52. Bull Cancer. 1994. PMID: 7734766 Review. French.

2

[Metastases from cancers of unknown primary site. Data from 302 autopsies].

Le Cesne A, Le Chevalier T, Caille P, Cvitkovic E, Contesso G, Spielmann M, Rouesse J. Le Cesne A, et al. Among authors: le chevalier t. Presse Med. 1991 Sep 21;20(29):1369-73. Presse Med. 1991. PMID: 1835011 French.

3

High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.

Le Cesne A, Antoine E, Spielmann M, Le Chevalier T, Brain E, Toussaint C, Janin N, Kayitalire L, Fontaine F, Genin J, et al. Le Cesne A, et al. Among authors: le chevalier t. J Clin Oncol. 1995 Jul;13(7):1600-8. doi: 10.1200/JCO.1995.13.7.1600. J Clin Oncol. 1995. PMID: 7541449 Clinical Trial.

4

Impact of chemotherapy on survival in locally advanced non-small cell lung cancer: the Gustave-Roussy experience.

Le Cesne A, Le Chevalier T, Arriagada R. Le Cesne A, et al. Among authors: le chevalier t. Lung Cancer. 1995 Apr;12 Suppl 1:S79-85. doi: 10.1016/0169-5002(95)00423-x. Lung Cancer. 1995. PMID: 7551937 Review.

5

[Chemotherapy of metastatic soft tissue sarcoma].

Le Cesne A. Le Cesne A. Presse Med. 1995 Sep 16;24(26):1214-20. Presse Med. 1995. PMID: 7567851 Review. French.

6

[Importance of the initial chemotherapy dose in the treatment of small cell lung carcinoma: therapeutic perspectives].

Le Chevalier T, Le Cesne A, Arriagada R. Le Chevalier T, et al. Among authors: le cesne a. Bull Cancer. 1995;82 Suppl 1:24s-28s. Bull Cancer. 1995. PMID: 7626850 Clinical Trial. French.

7

Surgery for pulmonary metastases. Who are the 10-year survivors?

Girard P, Baldeyrou P, Le Chevalier T, Le Cesne A, Brigandi A, Grunenwald D. Girard P, et al. Among authors: le chevalier t, le cesne a. Cancer. 1994 Nov 15;74(10):2791-7. doi: 10.1002/1097-0142(19941115)74:10<2791::aid-cncr2820741008>3.0.co;2-q. Cancer. 1994. PMID: 7954238

8

Cisplatin-fotemustine combination in inoperable non-small cell lung cancer: preliminary report of a French multicentre phase II trial.

Rivière A, Le Cesne A, Berille J, Baio S, Le Chevalier T. Rivière A, et al. Among authors: le chevalier t, le cesne a. Eur J Cancer. 1994;30A(5):587-90. doi: 10.1016/0959-8049(94)90525-8. Eur J Cancer. 1994. PMID: 8080671 Clinical Trial.

9

The open reading frame I (ORF I)/ORF II part of the human T-cell leukemia virus type I X region is dispensable for p40tax, p27rex, or envelope expression.

Roithmann S, Pique C, Le Cesne A, Delamarre L, Pham D, Tursz T, Dokhélar MC. Roithmann S, et al. Among authors: le cesne a. J Virol. 1994 May;68(5):3448-51. doi: 10.1128/JVI.68.5.3448-3451.1994. J Virol. 1994. PMID: 8151807 Free PMC article.

10

Phase I-II and pharmacokinetic study of a new fotemustine schedule in advanced non-small cell lung cancer.

Le Cesne A, Chabot G, Bérille J, Lucas C, Baud M, Gouyette A, Marty M, Le Chevalier T. Le Cesne A, et al. Among authors: le chevalier t. Lung Cancer. 1995 Aug;13(1):69-78. doi: 10.1016/0169-5002(95)00479-k. Lung Cancer. 1995. PMID: 8528641 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

449 results

Search Page

Filters